Skip to main content
. 2019 Aug 12;11(8):1153. doi: 10.3390/cancers11081153

Figure 1.

Figure 1

The scheme of the interactions of immune cells with prostate cancer progression and the interventions against inflammation. NSAIDs, non-steroidal anti-inflammatory drugs; IL, interleukin; STAT, signal transducer and activator of transcription; MDSCs, myeloid-derived suppressor cells; AR, androgen receptor.